Thus, HDAC inhibition with dacinostat reinstalls a transcriptionally permissive state at RARb2 regulatory elements and restores the dependence of tumor cells to the retinoic acid tumor suppressive effect, an alteration that can be exploited therapeutically. The gene discussed is HDAC9; the disease is neoplasm.